Results 111 to 120 of about 6,069 (180)

Leveraging a synthetic biology approach to enhance BCG-mediated expansion of Vγ9Vδ2 T cells. [PDF]

open access: yesPLoS One
Qabar CM   +7 more
europepmc   +1 more source

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. [PDF]

open access: yesAnn Hematol
Yamada T   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy